Ian Forster
Has grant
Senior Principal Research Fellow
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Structure-function studies on sodium-coupled neutral amino acid cotransporters
Open Date: 2013-04-01
Close Date: 2015-05-31
Grant: Close
Mechanisms of sodium-coupled cotransport of inorganic phosphate and neutral amino acids
Open Date: 2010-02-01
Close Date: 2013-03-31
Grant: Close
Cellular/molecular mechanisms in renal handling of inorganic anions (mostly phosphate)
Open Date: 2002-10-01
Close Date: 2010-01-31
Grant: Close
Molecular physiology of small intestinal absorption of inorganic phosphate
Open Date: 2001-04-01
Close Date: 2005-09-30
Grant: Close
The rectifying properties of neuronal nicotinic acetylcholine receptors expressed in oocytes
Open Date: 1993-04-01
Close Date: 1995-03-31
Articles (6)
Year:
2026
We used voltage clamp fluorometry to probe the movement of the S4 helix in the voltage-sensing domain of the sea urchin HCN channel (spHCN) expressed in Xenopus oocytes. We obtained markedly different fluorescence responses with either ALEXA-488 or MTS-TAMRA covalently linked to N-terminal Cys332 of the S4 helix. With hyperpolarizing steps, ALEXA-488 fluorescence increased rapidly, consistent with it reporting the initial inward movement of S4, as previously described. In contrast, MTS-TAMRA fluorescence increased more slowly and its early phase correlated with that of channel opening. Additionally, a slow fluorescence component that tracked the development of the mode shift, or channel hysteresis, could be resolved with both labels. We quantitated this component as an increased deactivation tail current delay with concomitantly longer activation periods and found it to depend strongly on the presence of K+ ions in the pore. Using collisional quenching experiments and structural predictions, we established that ALEXA-488 was more exposed to solvent than MTS-TAMRA. We propose that components of S4 movement during channel activation can be kinetically resolved using different fluorescent probes to reveal distinct biophysical properties. Our findings underscore the need to apply caution when interpreting voltage clamp fluorometry data and demonstrate the potential utility of different labels to interrogate distinct biophysical properties of voltage-gated membrane proteins.
Year:
2024
Hyperpolarization activated Cyclic Nucleotide (HCN) gated channels are crucial for various neurophysiological functions, including learning and sensory functions, and their dysfunction are responsible for brain disorders, such as epilepsy. To date, HCN2 variants have only been associated with mild epilepsy and recently, one monoallelic missense variant has been linked to developmental and epileptic encephalopathy. Here, we expand the phenotypic spectrum of HCN2- related disorders by describing twenty-one additional individuals from fifteen unrelated families carrying HCN2 variants. Seventeen individuals had developmental delay/intellectual disability (DD/ID), two had borderline DD/ID, and one had borderline DD. Ten individuals had epilepsy with DD/ID, with median age of onset of 10 months, and one had epilepsy with normal development. Molecular diagnosis identified thirteen different pathogenic HCN2 variants, including eleven missense variants affecting highly conserved amino acids, one frameshift variant, and one in-frame deletion. Seven variants were monoallelic of which five occurred de novo, one was not maternally inherited, one was inherited from a father with mild learning disabilities, and one was of unknown inheritance. The remaining six variants were biallelic, with four homozygous and two compound heterozygous variants. Functional studies using two-electrode voltage-clamp recordings in Xenopus laevis oocytes were performed on three monoallelic variants, p.(Arg324His), p.(Ala363Val), and p.(Met374Leu), and three biallelic variants, p.(Leu377His), p.(Pro493Leu) and p.(Gly587Asp). The p.(Arg324His) variant induced a strong increase of HCN2 conductance, while p.(Ala363Val) and p.(Met374Leu) displayed dominant negative effects, leading to a partial loss of HCN2 channel function. By confocal imaging, we found that the p.(Leu377His), p.(Pro493Leu) and p.(Gly587Asp) pathogenic variants impaired membrane trafficking, resulting in a complete loss of HCN2 elicited currents in Xenopus oocytes. Structural 3D-analysis in depolarized and hyperpolarized states of HCN2 channels, revealed that the pathogenic variants p.(His205Gln), p.(Ser409Leu), p.(Arg324Cys), p.(Asn369Ser) and p.(Gly460Asp) modify molecular interactions altering HCN2 function. Taken together, our data broadens the clinical spectrum associated with HCN2 variants, and disclose that HCN2 is involved in developmental encephalopathy with or without epilepsy.
Year:
2024
Voltage clamp fluorometry was used to probe the S4 helix movement in the voltage sensing domain of the sea urchin HCN channel expressed in Xenopus oocytes. Markedly different fluorescence responses were obtained with either ALEXA-488 or MTS-TAMRA covalently linked to Cys332 at the N-terminal end of S4. With hyperpolarizing steps, ALEXA-488 fluorescence increased rapidly showing characteristics consistent with it reporting the initial inward movement of S4 in agreement with previous studies. In contrast, MTS-TAMRA fluorescence was slower and correlated with the early phase of channel opening. In addition, a slow fluorescence component was resolved with both labels that tracked the development of the mode shift or channel hysteresis. This was quantitated as an increased deactivation tail current delay with concomitantly longer activation periods and was found to depend strongly on the presence of K + ions in the pore. This indicated that the microenvironment of the fluorescent probes attached to Cys332 was strongly influenced by conformational changes in the pore domain. Collisional quenching experiments established that ALEXA-488 was more exposed to solvent than MTS-TAMRA. This was supported by structural predictions based on homology modelling of spHCN in the closed and open conformations with covalently linked fluorophores. This study demonstrates that components of S4 movement during channel activation can be kinetically resolved using different fluorescent probes to reveal three distinct biophysical properties: voltage-sensor movement, early channel opening and mode-shift. These data support the use of different labelling probes to interrogate distinct biophysical aspects of voltage-gated membrane proteins. Summary Voltage clamp fluorometry was used to probe the S4 helix movement in the voltage sensing domain of the spHCN channel expressed in Xenopus oocytes, labeled with either ALEXA-488 or MTS-TAMRA. Each fluorophore reported different components of S4 movement.
Year:
2024
Pathogenic variants in HCN1 causing cation leak result in a severe developmental and epileptic encephalopathy (DEE). Current treatment options for patients with HCN1 -DEE are limited and are insufficient to fully address both the seizures and clinical comorbidities of this disorder. Org 34167 is a brain penetrant broad-spectrum HCN channel inhibitor that has completed phase I clinical trials. We used a range of assays at molecular, cellular, network and behavioural levels to explore the potential of Org 34167 as a precision medicine for HCN1 -DEE. Org 34167 restored the voltage sensitivity of the DEE HCN1 M305L mutated channel, significantly reducing cation leak. It also restored I h -mediated ‘sag’, hyperpolarised the resting membrane potential and reduced firing of layer V neurons from the Hcn1 M294L mouse model of HCN1 -DEE, which was engineered based on the HCN1 M305L pathogenic variant. Additionally, Org 34167 reduced neuronal epileptiform activity and restored retinal light sensitivity in these mice, suggesting it may improve both seizures and other clinical comorbidities. However, Org 34167-mediated tremors were noted at therapeutic doses. Org 34167 was also effective at reducing cation leak caused by five additional HCN1 pathogenic variants, suggesting broader utility. Overall, these data demonstrate that a small molecule HCN inhibitor can restore channel and consequent physiological functions, positioning it as a promising precision therapeutic approach for HCN1 -DEE.
Year:
2024
Year:
2023
Collaborators (12)
Rikke S. Møller
University of Southern Denmark
Patrick Van Bogaert
Université d'Angers
Reza Maroofian
-
Henry Houlden
Professor of Neurogenetics
-
Bang Bui
Associate Professor
University of Melbourne
Rami Abou Jamra
University Hospital Leipzig
Christian LEGROS
Director - Professor in Neurosciences
Université d'Angers
Andrew Hung
Senior Lecturer
RMIT University
Steffen Syrbe
Director ad Interim Clinic 5, Full Professor, Consultant Neuropediatrics and Pediatrics, Head of Division for Pediatric Epileptology
Heidelberg University
Thomas Smol
PU-PH
Université de Lille
Christopher Reid
University of Melbourne
Anne O'Donnell-Luria
Associate Professor
Boston Children's Hospital
Make your next move.
Prepare your application
Review drafts before you send them.